1. Home
  2. COGT vs IFS Comparison

COGT vs IFS Comparison

Compare COGT & IFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cogent Biosciences Inc.

COGT

Cogent Biosciences Inc.

HOLD

Current Price

$38.74

Market Cap

6.2B

Sector

Health Care

ML Signal

HOLD

Logo Intercorp Financial Services Inc.

IFS

Intercorp Financial Services Inc.

HOLD

Current Price

$56.34

Market Cap

6.4B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
COGT
IFS
Founded
2014
1897
Country
United States
Peru
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Commercial Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
6.4B
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
COGT
IFS
Price
$38.74
$56.34
Analyst Decision
Strong Buy
Buy
Analyst Count
15
1
Target Price
$36.21
$48.00
AVG Volume (30 Days)
2.7M
384.3K
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
3.85%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,871,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1,733.58
$7.38
P/E Ratio
N/A
$9.61
Revenue Growth
N/A
N/A
52 Week Low
$8.80
$35.45
52 Week High
$43.73
$58.16

Technical Indicators

Market Signals
Indicator
COGT
IFS
Relative Strength Index (RSI) 71.85 62.82
Support Level $37.54 $43.65
Resistance Level $40.62 $58.16
Average True Range (ATR) 1.49 2.01
MACD 0.71 -0.03
Stochastic Oscillator 87.34 78.25

Price Performance

Historical Comparison
COGT
IFS

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

About IFS Intercorp Financial Services Inc.

Intercorp Financial Services Inc is a provider of banking, insurance, wealth management services, and payments for retail customers and commercial clients in Peru. Its purpose is centered around building financial well-being together. The company has three operating business segments: Banking, mainly loans, credit facilities, deposits, and current accounts; Insurance provides life annuity products with single-premium payment and conventional life insurance products, as well as other retail insurance products; and Wealth management provides brokerage and investment management services. Inteligo serves mainly Peruvian citizens.

Share on Social Networks: